NEXT Oncology — Fairfax, Virginia

Public research footprint of NEXT Oncology, compiled from the ClinicalTrials.gov public registry.

180

Registered studies

132

Active

103

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Solid Tumor · Advanced Solid Tumors · mCRPC (Metastatic Castration-resistant Prostate Cancer) · NSCLC

Recently updated registry entries

NCT07719361 — A Study in Patients With Metastatic Castration-Resistant Prostate Cancer (Recruiting)
NCT07397338 — Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors (Recruiting)
NCT06128551 — Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at NEXT Oncology?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.